Amgen Tests New Way to Make Ebola Drug to Boost Supply
This article is for subscribers only.
Amgen Inc. said it will work with the Bill & Melinda Gates Foundation and other groups to come up with an alternative production method for ZMapp, the promising experimental drug to treat Ebola whose supply ran out in August.
Separately, the U.S. government has asked three specialized centers how they can expand manufacturing of the Ebola drug using the current method of tobacco plants.